p-hydroxymethamphetamine enantiomer pharmacokinetics and metabolism in rats

Absence of N-demethylation

A. Hutchaleelaha, Michael Mayersohn

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

p-hydroxymethamphetamine (OHMAP) is one of the major metabolites of the widely abused drug methamphetamine (MAP). The demethylation of OHMAP to p- hydroxyamphetamine (OHAP) has been shown in vitro but has never been reported in vivo. The disposition kinetics as well as the metabolism of OHMAP was investigated employing a sensitive HPLC method which can separate the enantiomers of OHMAP and OHAP. Both conjugated and unconjugated forms of these compounds can bc quantitated. Male Sprague Dawley rats were given an iv bolus oF racemic OHMAP (20mgkg-1) and serum and urine samples were collected at selected times. The serum concentration time data for OH MAP enantiomers could be described by a biexponential equation. Tile clearance of D-OHMAP (93.5mL min-1 kg -1) was slightly, but statistically significantly, greater than that of the L-enantiomer (83.9mL min-1 kg- 1). The steady-state volumes of distribution of L- and D-OHMAP were (mean±SD) 3.15±0.84 and 4.23±1.76L kg-1 respectively. No significant concentrations or amounts of OHAP enantiomers could he detected in any serum or urine sample. Rats excreted more unchanged L-OHMAP (34%) than D-OHMAP (29%). In contrast, more conjugated D-OHMAP (57%) was recovered compared to the conjugated L-OHMAP (52%). The results suggest that there is slight stereoselectivity in the disposition of OHMAP enantiomers. The N- demethylation product (OHAP) was not produced in vivo.

Original languageEnglish (US)
Pages (from-to)423-432
Number of pages10
JournalBiopharmaceutics and Drug Disposition
Volume18
Issue number5
DOIs
StatePublished - Jul 1997

Fingerprint

p-Hydroxyamphetamine
Pharmacokinetics
Methamphetamine
Serum
Urine
Sprague Dawley Rats
High Pressure Liquid Chromatography
pholedrine
Pharmaceutical Preparations

Keywords

  • N- demethylation
  • P-hydroxymethamphetamine
  • Pharmacokinetics
  • Stereoselectivity

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

p-hydroxymethamphetamine enantiomer pharmacokinetics and metabolism in rats : Absence of N-demethylation. / Hutchaleelaha, A.; Mayersohn, Michael.

In: Biopharmaceutics and Drug Disposition, Vol. 18, No. 5, 07.1997, p. 423-432.

Research output: Contribution to journalArticle

@article{4656ebf27c3a46e5bf0e0e117802a617,
title = "p-hydroxymethamphetamine enantiomer pharmacokinetics and metabolism in rats: Absence of N-demethylation",
abstract = "p-hydroxymethamphetamine (OHMAP) is one of the major metabolites of the widely abused drug methamphetamine (MAP). The demethylation of OHMAP to p- hydroxyamphetamine (OHAP) has been shown in vitro but has never been reported in vivo. The disposition kinetics as well as the metabolism of OHMAP was investigated employing a sensitive HPLC method which can separate the enantiomers of OHMAP and OHAP. Both conjugated and unconjugated forms of these compounds can bc quantitated. Male Sprague Dawley rats were given an iv bolus oF racemic OHMAP (20mgkg-1) and serum and urine samples were collected at selected times. The serum concentration time data for OH MAP enantiomers could be described by a biexponential equation. Tile clearance of D-OHMAP (93.5mL min-1 kg -1) was slightly, but statistically significantly, greater than that of the L-enantiomer (83.9mL min-1 kg- 1). The steady-state volumes of distribution of L- and D-OHMAP were (mean±SD) 3.15±0.84 and 4.23±1.76L kg-1 respectively. No significant concentrations or amounts of OHAP enantiomers could he detected in any serum or urine sample. Rats excreted more unchanged L-OHMAP (34{\%}) than D-OHMAP (29{\%}). In contrast, more conjugated D-OHMAP (57{\%}) was recovered compared to the conjugated L-OHMAP (52{\%}). The results suggest that there is slight stereoselectivity in the disposition of OHMAP enantiomers. The N- demethylation product (OHAP) was not produced in vivo.",
keywords = "N- demethylation, P-hydroxymethamphetamine, Pharmacokinetics, Stereoselectivity",
author = "A. Hutchaleelaha and Michael Mayersohn",
year = "1997",
month = "7",
doi = "10.1002/(SICI)1099-081X(199707)18:5<423::AID-BDD30>3.0.CO;2-Y",
language = "English (US)",
volume = "18",
pages = "423--432",
journal = "Biopharmaceutics and Drug Disposition",
issn = "0142-2782",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - p-hydroxymethamphetamine enantiomer pharmacokinetics and metabolism in rats

T2 - Absence of N-demethylation

AU - Hutchaleelaha, A.

AU - Mayersohn, Michael

PY - 1997/7

Y1 - 1997/7

N2 - p-hydroxymethamphetamine (OHMAP) is one of the major metabolites of the widely abused drug methamphetamine (MAP). The demethylation of OHMAP to p- hydroxyamphetamine (OHAP) has been shown in vitro but has never been reported in vivo. The disposition kinetics as well as the metabolism of OHMAP was investigated employing a sensitive HPLC method which can separate the enantiomers of OHMAP and OHAP. Both conjugated and unconjugated forms of these compounds can bc quantitated. Male Sprague Dawley rats were given an iv bolus oF racemic OHMAP (20mgkg-1) and serum and urine samples were collected at selected times. The serum concentration time data for OH MAP enantiomers could be described by a biexponential equation. Tile clearance of D-OHMAP (93.5mL min-1 kg -1) was slightly, but statistically significantly, greater than that of the L-enantiomer (83.9mL min-1 kg- 1). The steady-state volumes of distribution of L- and D-OHMAP were (mean±SD) 3.15±0.84 and 4.23±1.76L kg-1 respectively. No significant concentrations or amounts of OHAP enantiomers could he detected in any serum or urine sample. Rats excreted more unchanged L-OHMAP (34%) than D-OHMAP (29%). In contrast, more conjugated D-OHMAP (57%) was recovered compared to the conjugated L-OHMAP (52%). The results suggest that there is slight stereoselectivity in the disposition of OHMAP enantiomers. The N- demethylation product (OHAP) was not produced in vivo.

AB - p-hydroxymethamphetamine (OHMAP) is one of the major metabolites of the widely abused drug methamphetamine (MAP). The demethylation of OHMAP to p- hydroxyamphetamine (OHAP) has been shown in vitro but has never been reported in vivo. The disposition kinetics as well as the metabolism of OHMAP was investigated employing a sensitive HPLC method which can separate the enantiomers of OHMAP and OHAP. Both conjugated and unconjugated forms of these compounds can bc quantitated. Male Sprague Dawley rats were given an iv bolus oF racemic OHMAP (20mgkg-1) and serum and urine samples were collected at selected times. The serum concentration time data for OH MAP enantiomers could be described by a biexponential equation. Tile clearance of D-OHMAP (93.5mL min-1 kg -1) was slightly, but statistically significantly, greater than that of the L-enantiomer (83.9mL min-1 kg- 1). The steady-state volumes of distribution of L- and D-OHMAP were (mean±SD) 3.15±0.84 and 4.23±1.76L kg-1 respectively. No significant concentrations or amounts of OHAP enantiomers could he detected in any serum or urine sample. Rats excreted more unchanged L-OHMAP (34%) than D-OHMAP (29%). In contrast, more conjugated D-OHMAP (57%) was recovered compared to the conjugated L-OHMAP (52%). The results suggest that there is slight stereoselectivity in the disposition of OHMAP enantiomers. The N- demethylation product (OHAP) was not produced in vivo.

KW - N- demethylation

KW - P-hydroxymethamphetamine

KW - Pharmacokinetics

KW - Stereoselectivity

UR - http://www.scopus.com/inward/record.url?scp=0030756280&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030756280&partnerID=8YFLogxK

U2 - 10.1002/(SICI)1099-081X(199707)18:5<423::AID-BDD30>3.0.CO;2-Y

DO - 10.1002/(SICI)1099-081X(199707)18:5<423::AID-BDD30>3.0.CO;2-Y

M3 - Article

VL - 18

SP - 423

EP - 432

JO - Biopharmaceutics and Drug Disposition

JF - Biopharmaceutics and Drug Disposition

SN - 0142-2782

IS - 5

ER -